1-12 of 12
Katharina Goetze, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Age and Midostaurin-Dose on Response and Outcome in Acute Myeloid Leukemia with FLT3 -ITD: Interim-Analyses of the AMLSG 16-10 Trial

Richard F. Schlenk, MD, Walter Fiedler, MD, Helmut R. Salih, MD, Gerald Wulf, MD, Felicitas Thol, MD, Andrea Kündgen, MD, Thomas Kindler, MD, Hans-Juergen Salwender, MD, Michael Lübbert, MD, Peter Brossart, MD, Jörg Westermann, MD Prof, Doris Kraemer, MD, Katharina Goetze, MD, Heinz-August Horst, MD PhD, Jürgen Krauter, MD, Michael Girschikofsky, MD, Mark Ringhoffer, MD, Thomas Südhoff, MD, Gerhard Held, MD, Hartmut H. Kirchner, MD, Wolff Schmiegel, MD, Richard Greil, MD, Martin Griesshammer, MD, Elisabeth Lange, MD, Uwe Martens, MD, Bernd Hertenstein, MD, Maike de Wit, Elisabeth Koller, MD, Andreas L. Petzer, MD, Tanja Hesse, MD, Volker Runde, MD, Peter Reimer, MD, Beate S. Schultheis, MD, Heinz Kirchen, MD, Frank Griesinger, MD, Holger Hebart, MD, Gerhard Heil, Stephan Kremers, David Nachbaur, MD, Nadezda Basara, MD, Carsten Schwänen, Daniel Schöndube, MD, Jochen Greiner, Anja Münnich, Daniela Weber, Verena I. Gaidzik, MD, Maria-Veronica Teleanu, MD, Peter Paschka, MD, Frauke Theis, Axel Benner, Michael Heuser, MD, Konstanze Döhner, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2016) 128 (22): 449.
https://doi.org/10.1182/blood.V128.22.449.449
Published: 2016
Journal Articles

Monitoring of Minimal Residual Disease (MRD) of DNMT3A Mutations (DNMT3A mut ) in Acute Myeloid Leukemia (AML): A Study of the AML Study Group (AMLSG)

Verena I. Gaidzik, MD, Daniela Weber, Peter Paschka, MD, Anna Kaumanns, Stefan Krieger, Andrea Corbacioglu, PhD, Jan Kroenke, MD, Silke Kapp-Schwoerer, MD, Doris Krämer, MD, Heinz A. Horst, MD PhD, Ingo Schmidt-Wolf, MD, Gerhard Held, MD, Andrea Kuendgen, MD, Mark Ringhoffer, MD, Katharina Goetze, MD, Thomas Kindler, MD, Walter Fiedler, MD, Mohammad Amen Wattad, MD, Lars Bullinger, MD, Brigitte Schlegelberger, MD PhD, Felicitas Thol, MD, Michael Heuser, MD, Arnold Ganser, MD, Richard F. Schlenk, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2015) 126 (23): 226.
https://doi.org/10.1182/blood.V126.23.226.226
Published: 2015
Journal Articles

Application of a Short Tandem Repeat Based PCR Assay for Chronological Monitoring of Myelodysplastic Syndrome (MDS) Patients with Deletion of Chromosome 5q Following Lenalidomide Treatment

Johann-Christoph Jann, Daniel Nowak, MD, Florian Nolte, Stephanie Fey, Verena Nowak, Julia Oblaender, Jovita Pressler, Alice Charlotte Fabarius, PhD, Uwe Platzbecker, MD, Aristoteles Giagounidis, MD, Katharina Goetze, MD, Anne Letsch, Detlef Haase, MD, Richard F. Schlenk, MD, Gesine Bug, MD, Michael Luebbert, MD, Arnold Ganser, MD, Ulrich Germing, MD, Claudia Haferlach, MD, Wolf-Karsten Hofmann, MD, Maximilian Mossner
Journal: Blood
Blood (2015) 126 (23): 2891.
https://doi.org/10.1182/blood.V126.23.2891.2891
Published: 2015
Journal Articles

The Extent of Labile Plasma Iron (LPI) Predicts for Non-Relapse-Mortality (NRM) in AML and MDS Patients with Systemic Iron Overload Undergoing Allogenic Stem Cell Transplantation Results of the Prospective, German-Austrian Allive Trial

Martin Wermke, MD, Julia Eckoldt, Katharina Goetze, MD, Stefan A. Klein, Gesine Bug, MD, Friedrich Stölzel, MD, Malte von Bonin, MD, Johannes Schetelig, MD M. Sc,, Michael Laniado, MD, Verena Plodeck, MD, Wolf-Karsten Hofmann, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Dominik Wolf, MD, Igor Theurl, MDPhD, Uwe Platzbecker, MD
Journal: Blood
Blood (2015) 126 (23): 386.
https://doi.org/10.1182/blood.V126.23.386.386
Published: 2015
Journal Articles

Outcome of Patients Treated for Myelodysplastic Syndromes after Failure of Lenalidomide Therapy

Thomas Prebet, MD, Thomas Cluzeau, MDPhD, Sophie Park, MD PhD, Ulrich Germing, MD, Lionel Ades, MD PhD, Uwe Platzbecker, MD, Norbert Vey, Katharina Goetze, MD, Charikleia Kelaidi, MD, Esther Natalie Oliva, Najla H. Al Ali, BDS, MSc, Pierre Fenaux, MD PhD, Steven D. Gore, MD, Rami S. Komrokji, MD
Journal: Blood
Blood (2015) 126 (23): 95.
https://doi.org/10.1182/blood.V126.23.95.95
Published: 2015
Journal Articles

Outcome of Lower Risk Non Del 5q MDS after Failure of Erythropoiesis Stimulating Agents (ESA), and Impact of Post-ESA Treatment on Survival: A Retrospective European Study

Sophie Park, MD PhD, Jean-François Hamel, Andrea Toma, Charikleia Kelaidi, MD, Maria Campelo Diez, Valeria Santini, MD, Enrico Balleari, MD, Jennifer Schemenau, Rosa Sapena, Katharina Goetze, MD, Catharina Mueller-Thomas, MD, Odile Beyne-Rauzy, MD PhD, Aspasia Stamatoullas, MD, Ioannis Kotsianidis, Agnes Guerci, MD, Dominique Bordessoule, Pascale Cony-Makhoul, MD, Stéphane Cheze, MD PhD, Eric Wattel, MDPhD, Christian Rose, Norbert Vey, Ulrich Germing, MD, Guillermo Sanz, MD PhD, François Dreyfus, MD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1665.
https://doi.org/10.1182/blood.V126.23.1665.1665
Published: 2015
Journal Articles

ACE-536 Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from a Phase 2 Study

Uwe Platzbecker, MD, Ulrich Germing, MD, Aristoteles Giagounidis, MD PhD, Katharina Goetze, MD, Philipp Kiewe, MD, Karin Mayer, MD, Oliver Ottman, MD, Markus P. Radsak, MD, Thomas Wolff, MD, Detlef Haase, MD, Monty Hankin, Dawn M. Wilson, Adberrahmane Laadem, MD, Matthew L. Sherman, MD, Kenneth M. Attie, MD
Journal: Blood
Blood (2014) 124 (21): 411.
https://doi.org/10.1182/blood.V124.21.411.411
Published: 2014
Journal Articles

Prospective Phase III Trial Of Valproic Acid (VPA) In Combination With All-Trans Retinoic Acid (ATRA) and Intensive Induction Therapy For AML In Older Patients: Final and Molecular Subset Analyses Of The AMLSG 06-04 Study

Michela Giulia Tassara, MD, Konstanze Döhner, MD, Peter Brossart, MD, Gerhard Held, Katharina Goetze, MD, Heinz-August Horst, MD, Mark Ringhoffer, MD, Claus-Henning Kohne, MD, Stephan Kremers, MD, Aruna Raghavachar, MD, Gerald Wulf, MD, Heinz Kirchen, MD, David Nachbaur, MD, Hans-Günter Derigs, M.D., Mohammed Wattad, MD, Elisabeth Koller, MD, Wolfram Brugger, MD, Axel C. Matzdorff, MD, PhD, Richard Greil, MD, Gerhard Heil, MD, Daniela Späth, MSc, Peter Paschka, MD, Verena I. Gaidzik, MD, Martin Göttlicher, M.D., Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2013) 122 (21): 3927.
https://doi.org/10.1182/blood.V122.21.3927.3927
Published: 2013
Journal Articles

Synergistic Reactivation Of Cancer/Testis Antigens By Combination Treatment With Decitabine and Histone Deacetylase Inhibitors (Valproate, Panobinostat) In Myeloid Leukemia Cells

Nadja Blagitko-Dorfs, Ph.D., Tobias Bauer, M.Sc., Maren Prinz, Wolfram Brugger, MD, Gesine Bug, MD, PhD, Katharina Goetze, MD, Michael Heuser, MD, Sabine Kayser, MD, Hans Walter Lindemann, MD, Helmut R. Salih, MD, Björn W. Hackanson, MD, Michael Lübbert, MD
Journal: Blood
Blood (2013) 122 (21): 3763.
https://doi.org/10.1182/blood.V122.21.3763.3763
Published: 2013
Journal Articles

Pharmacodynamic Analysis Of The Inhibitory Potency Of The Tyrosine Kinase Inhibitor Midostaurin In Combination With Intensive Chemotherapy Including Allogeneic Hematopoietic Stem Cell Transplantation Followed By Maintenance Therapy In FLT3 -ITD Positive Acute Myeloid Leukemia In The Ongoing AMLSG 16-10 Trial

Sabine Kayser, MD, Mark Levis, MD, PhD, Carina Morlok, Andrea Kuendgen, MD, Michael Heuser, MD, Walter Fiedler, MD, Joerg Westermann, MD, Katharina Goetze, MD, Helmut R. Salih, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Heinz A. Horst, MD, Uwe M. Martens, MD, Gerald Wulf, MD, Michael Luebbert, MD, Ph.D., Dominik Wolf, MD, Richard Greil, MD, Claus-Henning Koehne, MD, Mark Ringhoffer, MD, Hartmut Kirchner, MD, Michael Pfreundschuh, MD, Brigitte Schlegelberger, MD, PhD, Patricia Erdmann, Trivikram Rajkhowa, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Arnold Ganser, Hartmut Doehner, MD, Konstanze Doehner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2013) 122 (21): 1283.
https://doi.org/10.1182/blood.V122.21.1283.1283
Published: 2013
Journal Articles

Impact Of The Pretreatment Characteristics As Well As Cyto- and Molecular-Genetic Profile On Outcome After Relapse In Acute Myeloid Leukemia

Richard F. Schlenk, MD, Peter Frech, Sabine Kayser, MD, Daniela Späth, MSc, Peter Brossart, MD, Heinz-August Horst, MD, Doris M Kraemer, M.D., Gerhard Held, Mark Ringhoffer, MD, Alexander Burchardt, M.D., Andrea Kündgen, M.D., Katharina Goetze, MD, David Nachbaur, MD, Thomas Kindler, MD, Michael Lübbert, MD, Helmut R. Salih, MD, Hans Salwender, MD, Gerald Wulf, MD, Elisabeth Koller, MD, Mohammed Wattad, MD, Walter Fiedler, MD, Stephan Kremers, MD, Heinz Kirchen, MD, Bernd Hertenstein, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Michael Heuser, MD, Felicitas Thol, MD, Arnold Ganser, MD, Konstanze Döhner, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 830.
https://doi.org/10.1182/blood.V122.21.830.830
Published: 2013
Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.

Richard F. Schlenk, MD, Konstanze Doehner, MD, Martina Kerz, Frank Hartmann, MD, Francesco del Valle, MD, Axel Glasmacher, MD, Hans Pralle, MD, Katharina Goetze, MD, Elisabeth Koller, MD, Guenther Gastl, MD, Hans G. Mergenthaler, MD, Hans Salwender, MD, Heinz Kirchen, MD, Detlef Haase, MD, Stephan Kremers, MD, Christoph Nerl, MD, Matthias Theobald, MD, Axel C. Matzdorff, MD, Arnold Ganser, MD, Hartmut Doehner, MD, for the German-Austrian, AML Study Group (AMLSG)
Journal: Blood
Blood (2005) 106 (11): 1849.
https://doi.org/10.1182/blood.V106.11.1849.1849
Published: 2005